investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Tsc1/mTOR axis in immune homeostasis and tumorigenesis
Hongbo Chi
0 Collaborator(s)
Funding source
National Institutes of Health (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Hongbo Chi
St. Jude Children's Research Hospital
Memphis, United States
Related projects
David H Haussler
Center for Big Data in Translational Genomics
Leukaemia
John D Schuetz
Metabolic pathways in leukemia
Leukaemia
Jon C Aster
Oncogenic Notch Signaling
Leukaemia
Pathology
Hematology and hematologic malignancies
Peter Aplan
Pre-clinical Studies of Therapy for Myelodysplastic Syndrome
Leukaemia
Hematology and hematologic malignancies
Zhe Li
IGF/IGF1R signaling in hematopoiesis and leukemogenesis
Leukaemia
Michael Kharas
Characterizing MSI2 in leukemia
Leukaemia
Richard A Flavell
Understanding Hemotopoietic Neoplasias using Humanized Mice
Leukaemia
Pathology
Hematology and hematologic malignancies
Derek B. Sant'Angelo
Control of cytokine production by human NK cells
Leukaemia
Alex Kentsis
Aberrant activation of HGF/MET signaling as a therapeutic target in AML
Leukaemia